VCI Global Limited (NASDAQ:VCIG) is a diversified holding company. Through its subsidiaries, it focuses on consulting, fintech, AI, robotics, and cybersecurity. Based in Kuala Lumpur, Malaysia, our main operations are centered in Asia, with significant visibility across Asia Pacific, the United States, Europe, and the Middle East. VCIG primarily offers consulting services in capital markets, real estate, AI, and technology. In technology businesses, the company operates a proprietary financing platform that serves companies and individuals, as well as a secured messaging platform serving governments and organizations. We also invest, incubate, accelerate, and commercialize businesses and technologies in AI and robotics.

Brian Foote, CEO of HUMBL, individually shares his perspectives on recent developments and the Company's ongoing business operations. Moreover, he will deliver a Q&A of top questions raised by shareholders to the Company’s new investor relations firm SmallCapVoice.com, underscoring the Company’s commitment to transparent communication and engagement with its investor community.

“We are deeply focused on the HUMBL Wallet for private and public sector clients and are underway on work in both segments in areas such as sports leagues and municipal government. We look forward to sharing routine progress and investor relations updates with our HUMBL Community via SmallCapVoice.com,” said Brian Foote, CEO of HUMBL. “We’re pleased to begin these quarterly shareholder Q&A updates to do so.”

SmallCapVoice.com Inc. (“SCV”) announces the availability of a new audio interview with Dr. Bill Williams, CEO of BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT), to discuss the recent news and milestones for the Company. News covered in the interview includes: The closing of the previously announced plan of arrangement spinout transaction (the "Arrangement") pursuant to which certain pipeline assets of the Company, including Bria-TILsRx and protein kinase C delta (PKCδ) inhibitors for multiple indications including cancer (the "SpinCo Assets"), were spun-out to BriaPro Therapeutics Corp. ("SpinCo"), resulting in a 2/3rd owned subsidiary of the Company with the remaining 1/3rd held by BriaCell shareholders ("BriaCell Shareholders"). The acceptance of a letter of intent from Dr. Massimo Cristofanilli, Director of Breast Medical Oncology and Associate Director of Precision Medicine in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, outlining the parties’ plans and commitment, upon regulatory approval, to initiate a Phase 2 investigator-initiated clinical study to evaluate BriaCell’s novel immunotherapy, Bria-IMT, in combination with a check point inhibitor (CPI), in early stage, newly diagnosed, high-risk triple negative breast cancer (TNBC) patients in the neoadjuvant setting. Finally, the news regarding the National Cancer Institute (NCI), the United States federal government's principal agency for cancer research and training, has awarded the Company a research grant to advance its platform of personalized off-the-shelf immunotherapies for cancer.

Cliff Emmons, CEO of IIOT-OXYS, Inc. (Oxys) stated, "We're pleased to announce the first half year of revenue in 2023 was a significant improvement over the same period in 2022 (an increase of 376%) and sustained the revenue momentum achieved throughout 2022. We expect this momentum achieved in the first half of 2023 will continue through the remainder of 2023 - given adequate funding to fuel sales & marketing efforts. Our leadership team also managed costs well, lowering operating expenses by 24%.

Our strong six months revenue and our confidence this momentum will continue through 2023, and beyond, are based on the following factors:

Our current DOT Bridge Monitoring Contract and overall Structural Health Monitoring ("SHM") vertical is the foundation of our revenue momentum. The current monitoring revenue will continue through the second half of 2023, with the previously approved expansion to continue beyond June. We believe our discussions with our main contractor to the DOT for extensions and expansions have been favorable. We also believe that prospects with our current DOT state, and DOT contacts in two other northeast states bode well for future business in mid-2024. There is still potential for local municipalities in our current northeast state to contribute revenue in the second half of 2023 and into 2024.

Our Smart Manufacturing vertical is benefiting from the progress on our CNC Proof of Concept ("POC"), that successfully concluded in May 2023, and has resulted in a signed Software-as-a-Service ("SaaS") contract in June 2023. Public endorsements and promotional videos have begun and more are forthcoming featuring our Smart Manufacturing customer, Precision Metal Products Inc. We believe these endorsements and promotional videos will lead to other paid CNC POCs and additional SaaS contracts, which would contribute to revenue in the second half of 2023 and beyond. It is expected these endorsements will also strengthen our position to secure additional POCs for other discrete manufacturing processes, including metal stamping, plastic injection molding, plastic extrusion, and automated assembly and test.

Our Strategic Partnership development continues to be a "force multiplier" for us. The strength of our Aingura IIoT, S.L. partnership provides supplemental expertise, equipment and software, which ensures we continue to bring value to our customers. We will also continue to develop some of our other previously announced partnerships.

We believe that our business development in these industries has high potential for success, due to the strength of their size and growth. The global smart manufacturing (also known as Industry 4.0) was $97.6 billion in 2022 and will reach $228.3 billion by 2027 (CAGR 18.5%),1 and the worldwide SHM industry was $2.0 billion in 2021 and will reach $4.0 billion by 2027 (CAGR of 14.6%).2

Among our many tailwinds, we do some headwinds. First, we have decided to discontinue our efforts with Aretas Sensor Networks ("Aretas") in the Indoor Air Quality ("IAQ") vertical and re-direct those resources to our better performing verticals. The second significant headwind is, since February, we have been unable to raise funds for ongoing operations through our existing financing agreements due to market conditions. Our CEO and COO have not received any compensation since mid-April (their salaries have accrued), and the lack of funds have significantly limited sales and marketing efforts. Our management is working to secure funding from our lead investor to pay for ongoing expenses and the leadership team is considering many options for both the short and long term. These options will depend largely upon our ability to continue to raise funds and implement a marketing and sales plan. In the event we are unable to raise adequate funds, management may need to consider other options such as pursuing suitable companies to merge with or acquire us.

Overall,

SmallCapVoice.com Inc, is thrilled to announce the availability of an exclusive interview featuring Tim Fernback, the CEO of Grid Battery Metals (TSXV: CELL) (OTCQB: EVKRF) (FRA: NMK2), as he delves into the exciting prospects of nickel and lithium in the rapidly expanding electric vehicle (EV) and battery sectors.

Grid Battery Metals, a pioneering company, is strategically positioned in the battery metals market, with a strong focus on nickel and lithium. As the demand for EVs and battery technologies soars, both nickel and lithium are projected to experience significant growth over the next decade.

In the insightful interview, Tim Fernback share how as the world transitions towards sustainable energy solutions, the demand for electric vehicles and energy storage systems is escalating. Nickel and lithium play crucial roles in advancing these technologies, and Grid Battery Metals is capitalizing on this opportunity by concentrating its efforts on these two essential battery metals. Tim then goes on to explain the connection between Grid Battery Metals and their partner, Surge Battery Metals (TSXV:NILI)(OTC PINK:NILIF)(FRA:DJ5C).

Under Tim Fernback's visionary leadership, Grid Battery Metals has established itself as a leading player in the battery metals market. By honing in on nickel and lithium, the company is poised to meet the burgeoning demand for these metals, which are essential for the future of the EV and battery industries, through their 4 projects; Texas Spring, Clayton Valley, Grid Nickel, and Volt Canyon. The 2 nickel projects are located near FPX.

Grid Nickel is of extra special interest, and Tim goes on to explain the abundance of awaruite, which is a naturally occurring nickel-iron alloy important in the manufacturing of environmentally efficient batteries for the electric vehicle markets globally.

Tim continues to discuss company goals, including the recent shareholder update released by the company. The update included key highlights like a nickel project in British Columbia completing and the beginning of a lithium project at the Texas Spring and the Volt Canyon projects, both located in Nevada. Among other stated goals, Tim concludes by stating the company hopes to be ready for the 2024 drilling season.

The interview concludes discussing the companies balance sheets and sustainability in the current economic state of both the US and Canada. “We’re really well funded,” Tim states, “we just completed two financings for the company and we have over $4.5 million in just cash related working capital on our balance sheet.” Tim goes on to explain the additional capital on hand from the sale of property to Surge Battery Metals.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage immunotherapy company driven to fight cancer and improve patients’ lives, announces that it has received approval from FDA on its pivotal registrational study design for Bria-IMT in combination with a checkpoint inhibitor in advanced metastatic breast cancer.

FDA has approved the study design, the primary and secondary endpoints, and patient population in BriaCell’s upcoming pivotal registration clinical study. The study will include advanced metastatic breast cancer patients who have exhausted all other treatment options.

BriaCell is a clinical stage immunotherapy company developing novel treatments that boost the ability of the body’s own cancer fighting cells to destroy cancer. More information is available at https://briacell.com/.

The Leadership of Luminar Media Group, Inc. Discuss the Business Plan and Science Behind Their Ultra-Premium, Top-Shelf Vodka in Audio Interview with SmallCapVoice.com

Royale de Monte Carlo, headquartered in Miami, Florida, is an ultra-premium, icy cool, and deliciously smooth vodka sure to give long-lasting euphoric pleasure to any palate it graces. Created and produced by fifth generation master distillers located in the heart of the world-famous Cognac region of France, Royale de Monte Carlo was voted as the "World's Most Prestigious Vodka". https://royaledemontecarlo.com/

Experience the joy of royalty with every sip of Royale de Monte Carlo, and relish in its remarkable tasting notes. Boasting a pure, odorless profile with a refined, exotic finish, this transcendent vodka offers subtle hints of corduroy, cognac barrel, and slate, with undertones of grain mash and husk. Its silky-smooth texture, enhanced by nanotechnology, exudes a sweet, moderately grainy taste, culminating in a dry, intense finale featuring magnificent notes of champagne.

Nightfood CEO Sean Folkson provides updates on hotel distribution, recently initiated hotel and airline tests of Nightfood cookies as amenities, and answer investor questions.

Nightfood is pioneering the category of sleep-friendly nighttime snacks.

Over 80% of Americans snack regularly at night, resulting in an estimated 700 million nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion. The most popular choices are ice cream, cookies, chips, and candy. Recent research confirms such snacks, in addition to being generally unhealthy, can impair sleep, partly due to excess fat, sugar, and calories consumed before bed.

Nightfood’s sleep-friendly snacks are formulated by sleep and nutrition experts to contain less of those sleep-disruptive ingredients, along with a focus on ingredients and nutrients that research suggests can support nighttime relaxation and better sleep quality.

The brand is focused on establishing widespread national distribution of Nightfood ice cream, cookies, and other snack formats in the high-margin hotel vertical.

In March, 2023, Nightfood announced Sonesta International Hotels Corporation, the 8th largest hotel company in the United States, launched Nightfood ice cream into multiple Sonesta chains. Also in March, the Company announced its status as a Qualified Vendor of Choice Hotels, one of the world’s largest lodging franchisors.

Nightfood ice cream pints can be found in select locations of chains such as Sonesta, Courtyard by Marriott, Holiday Inn Express, Springhill Suites, Hyatt Place, Fairfield Inn & Suites and many more.

Hotels are increasingly focused on supporting guest wellness, and one way to do that is by offering healthier and sleep-friendly snacks in their grab-and-go lobby shops.

With an estimated 56,000 hotels across the United States, expanding distribution into a significant number of those hotels is expected to lead to profitability, consumer adoption of the nighttime snack category, and a strategically defensible position from which category leadership can be maintained.

Questions can be directed to [email protected]

By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.

SmallCapVoice.com Inc. (“SCV”) announces the availability of an interview with Bruce Rintoul, a key member of the SusGlobal Energy Corp. (OTCQB: SNRG) ("SusGlobal" or the "Company")Board of Directors, to discuss his work with the environmental, agricultural and industrial biotechnology company.

SusGlobal Energy Corp., the developer of SusGro™, an award winning and revolutionary pathogen free organic liquid fertilizer, is an environmental, agricultural and industrial biotechnology company focused on acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative product applications globally. It is management's objective to grow SusGlobal into a significant sustainable waste to energy and regenerative products provider and a trusted brand for the fertilizer, soil and aquaculture market, as LEADERS IN THE CIRCULAR ECONOMY®. For more information, please visit the SusGlobal website, Twitter and Facebook pages.

Cliff Emmons, CEO of IIOT-OXYS, Inc. (Oxys) stated, "We're pleased to announce, as promised, 2022 revenue exceeded 2021, doing so by more than seven-fold. This is the highest annual revenue since the negative impacts of the COVID pandemic. Also, as promised, revenue in the second half of 2022 exceeded that in the first half. Furthermore, fourth quarter revenue exceeded third quarter revenue, marking three consecutive quarters of increasing revenue. Our leadership team also managed costs well, lowering operating expenses by 17%, and professional expenses were reduced by 47%.

There were several factors that led to this strong growth in 2022, including the following:

Our Department of Transportation (DOT) Bridge Monitoring contract: We were awarded a six-figure sub-contract from a major northeast state's DOT for bridge monitoring, in addition to the extension that was given on the previous contract. This project will continue to contribute a strong revenue stream through mid-2023, and we're confident our performance will yield further extensions and expansions in the second half of the year.

Our continued focus on our Smart Manufacturing vertical enabled us to secure a CNC Proof of Concept (POC) contract in December 2022. The POC successfully kicked off in January 2023, is concluding next month, and is already yielding results that are impressing our customer. We expect a Software-as-a-Service (SaaS) contract to follow which we expect to contribute to revenue by the second half of 2023.

The ongoing strength of our strategic partnership with Aingura IIoT, S.L., which provides supplemental expertise, equipment and software, ensuring we continue to bring value to our customers.

Our partnership with a Canadian Indoor Air Quality Sensor and IIoT Platform company continues to progress well, and our retail sales efforts are beginning to show results.

Looking forward through 2023 and beyond, and as previously stated, we believe this is a transition year from "surviving" to "thriving". It is anticipated that 2023 YoY revenue growth will meet or exceed that of 2022. This will be accomplished through our partnerships, successful pilots, experienced leadership, and savvy technological talent. These capabilities will allow us to leverage our high potential growth markets: the global smart manufacturing (also known as Industry 4.0) was $97.6 B USD in 2022 and will reach $228.3 B USD by 2027 (CAGR 18.5%);[1] the worldwide Structural Health Monitoring (SHM) industry was $2.0 billion USD in 2021 and will reach $4.0 billion USD by 2027 (CAGR of 14.6%).[2] ; an Indoor Air Quality Monitors, which was estimated at $3.7 billion USD in 2020 and projected to reach $6.4 billion USD in 2027, growing at 8.2% CAGR.[3] By executing on these promises, we believe these revenue goals are achievable."